The late scientist and thinker Donald Braben argued that 20th-century breakthroughs arose from scientists being free to pursue bold ideas without pressure for quick results or rigid peer review. The rapid development of Covid-19 vaccines seemed to validate his claim: emergency conditions sped up trials, relaxed regulatory sequencing and encouraged scientists to share findings before peer review. Out of that sprang one of the great scientific success stories of our age: mRNA vaccines. These use synthetic genetic code to train the immune system to defend itself against viruses. Katalin Karikó and Drew Weissman, whose work enabled the mRNA Covid vaccine, went on to win the Nobel prize. Their breakthrough suggests that loosening traditional constraints could accelerate major scientific advances.
The extensive scientific and logistic infrastructure built during that period is now occupied with turning the technology towards other diseases: flu, HIV and even cancer. Until very recently, the US, which put more than $10bn into mRNA development, appeared primed to reap the scientific and commercial rewards. Despite the deregulatory zeal that birthed mRNA, the second Trump administration has rejected it. Instead, it has been remarkably steady in its commitment to the radical anti-science and anti-vaccine agenda of the US health secretary, Robert F Kennedy Jr. He has spent the past year undermining and outright sabotaging the US’s own success. Over the summer, the US Department of Health and Human Services announced a “coordinated wind-down” of federal funding for mRNA research, cancelling an additional $500m in funding for 22 projects.
